Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review

Stephen Corson, David Greenhalgh, Norah Elizabeth Palmateer, Amanda Weir, Sharon Hutchinson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In order to develop new ways to prevent Hepatitis C virus (HCV) transmission amongst injecting drug users (IDUs), it is necessary to fully understand the dynamics of this disease. We reviewed the evidence on three key areas of HCV transmission in this population: the rate of acute HCV infection amongst IDUs who have spontaneously resolved a previous infection, the rate of chronic HCV infection amongst IDUs who have spontaneously resolved a previous infection, and the ability of IDUs to be re-infected with either the same or a different HCV genotype. A literature search of PUBMED (January 1950 to January 2009), EMBASE (January 1980 to January 2009) and PsycINFO (January 1967 to January 2009) for English language, primary research papers was undertaken to identify longitudinal studies examining HCV re-infection following spontaneous viral clearance amongst IDUs. The systematic review identified three studies that satisfied the inclusion and exclusion criteria. Regarding the risk of acute HCV infection amongst IDUs, the findings from the three studies were conflicting and thus provided no compelling evidence in support of an increased or decreased risk of acute infection amongst IDUs who have spontaneously resolved compared to those previously uninfected. Limited evidence was found from two studies to support a reduced risk of subsequent chronic HCV infection in those who have previously spontaneously resolved an infection. Further, two studies found IDUs who spontaneously resolved an infection can be re-infected (with comparable proportions) with either the same or a different HCV genotype. The limited, and sometimes contradictory, evidence published in the worldwide literature highlights the need for more longitudinal studies of IDUs to fully understand the dynamics of the disease in this population.

Original languageEnglish
Pages (from-to)102-108
Number of pages7
JournalInternational Journal of Drug Policy
Volume22
Issue number2
Early online date26 Nov 2010
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Virus Diseases
Drug Users
Hepacivirus
Infection
Chronic Hepatitis C
Longitudinal Studies
Genotype
Aptitude
Population
Language
Research

Keywords

  • Hepatitic C
  • viruses
  • re infection
  • injecting drug users

Cite this

Corson, Stephen ; Greenhalgh, David ; Palmateer, Norah Elizabeth ; Weir, Amanda ; Hutchinson, Sharon. / Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review. In: International Journal of Drug Policy. 2011 ; Vol. 22, No. 2. pp. 102-108.
@article{e8200a0a0b79488d92d53bb9ec825c52,
title = "Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review",
abstract = "In order to develop new ways to prevent Hepatitis C virus (HCV) transmission amongst injecting drug users (IDUs), it is necessary to fully understand the dynamics of this disease. We reviewed the evidence on three key areas of HCV transmission in this population: the rate of acute HCV infection amongst IDUs who have spontaneously resolved a previous infection, the rate of chronic HCV infection amongst IDUs who have spontaneously resolved a previous infection, and the ability of IDUs to be re-infected with either the same or a different HCV genotype. A literature search of PUBMED (January 1950 to January 2009), EMBASE (January 1980 to January 2009) and PsycINFO (January 1967 to January 2009) for English language, primary research papers was undertaken to identify longitudinal studies examining HCV re-infection following spontaneous viral clearance amongst IDUs. The systematic review identified three studies that satisfied the inclusion and exclusion criteria. Regarding the risk of acute HCV infection amongst IDUs, the findings from the three studies were conflicting and thus provided no compelling evidence in support of an increased or decreased risk of acute infection amongst IDUs who have spontaneously resolved compared to those previously uninfected. Limited evidence was found from two studies to support a reduced risk of subsequent chronic HCV infection in those who have previously spontaneously resolved an infection. Further, two studies found IDUs who spontaneously resolved an infection can be re-infected (with comparable proportions) with either the same or a different HCV genotype. The limited, and sometimes contradictory, evidence published in the worldwide literature highlights the need for more longitudinal studies of IDUs to fully understand the dynamics of the disease in this population.",
keywords = "Hepatitic C, viruses, re infection, injecting drug users",
author = "Stephen Corson and David Greenhalgh and Palmateer, {Norah Elizabeth} and Amanda Weir and Sharon Hutchinson",
note = "Copyright {\circledC} 2010 Elsevier B.V. All rights reserved.",
year = "2011",
month = "3",
doi = "10.1016/j.drugpo.2010.10.007",
language = "English",
volume = "22",
pages = "102--108",
journal = "International Journal of Drug Policy",
issn = "0955-3959",
number = "2",

}

Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review. / Corson, Stephen; Greenhalgh, David; Palmateer, Norah Elizabeth; Weir, Amanda; Hutchinson, Sharon.

In: International Journal of Drug Policy, Vol. 22, No. 2, 03.2011, p. 102-108.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review

AU - Corson, Stephen

AU - Greenhalgh, David

AU - Palmateer, Norah Elizabeth

AU - Weir, Amanda

AU - Hutchinson, Sharon

N1 - Copyright © 2010 Elsevier B.V. All rights reserved.

PY - 2011/3

Y1 - 2011/3

N2 - In order to develop new ways to prevent Hepatitis C virus (HCV) transmission amongst injecting drug users (IDUs), it is necessary to fully understand the dynamics of this disease. We reviewed the evidence on three key areas of HCV transmission in this population: the rate of acute HCV infection amongst IDUs who have spontaneously resolved a previous infection, the rate of chronic HCV infection amongst IDUs who have spontaneously resolved a previous infection, and the ability of IDUs to be re-infected with either the same or a different HCV genotype. A literature search of PUBMED (January 1950 to January 2009), EMBASE (January 1980 to January 2009) and PsycINFO (January 1967 to January 2009) for English language, primary research papers was undertaken to identify longitudinal studies examining HCV re-infection following spontaneous viral clearance amongst IDUs. The systematic review identified three studies that satisfied the inclusion and exclusion criteria. Regarding the risk of acute HCV infection amongst IDUs, the findings from the three studies were conflicting and thus provided no compelling evidence in support of an increased or decreased risk of acute infection amongst IDUs who have spontaneously resolved compared to those previously uninfected. Limited evidence was found from two studies to support a reduced risk of subsequent chronic HCV infection in those who have previously spontaneously resolved an infection. Further, two studies found IDUs who spontaneously resolved an infection can be re-infected (with comparable proportions) with either the same or a different HCV genotype. The limited, and sometimes contradictory, evidence published in the worldwide literature highlights the need for more longitudinal studies of IDUs to fully understand the dynamics of the disease in this population.

AB - In order to develop new ways to prevent Hepatitis C virus (HCV) transmission amongst injecting drug users (IDUs), it is necessary to fully understand the dynamics of this disease. We reviewed the evidence on three key areas of HCV transmission in this population: the rate of acute HCV infection amongst IDUs who have spontaneously resolved a previous infection, the rate of chronic HCV infection amongst IDUs who have spontaneously resolved a previous infection, and the ability of IDUs to be re-infected with either the same or a different HCV genotype. A literature search of PUBMED (January 1950 to January 2009), EMBASE (January 1980 to January 2009) and PsycINFO (January 1967 to January 2009) for English language, primary research papers was undertaken to identify longitudinal studies examining HCV re-infection following spontaneous viral clearance amongst IDUs. The systematic review identified three studies that satisfied the inclusion and exclusion criteria. Regarding the risk of acute HCV infection amongst IDUs, the findings from the three studies were conflicting and thus provided no compelling evidence in support of an increased or decreased risk of acute infection amongst IDUs who have spontaneously resolved compared to those previously uninfected. Limited evidence was found from two studies to support a reduced risk of subsequent chronic HCV infection in those who have previously spontaneously resolved an infection. Further, two studies found IDUs who spontaneously resolved an infection can be re-infected (with comparable proportions) with either the same or a different HCV genotype. The limited, and sometimes contradictory, evidence published in the worldwide literature highlights the need for more longitudinal studies of IDUs to fully understand the dynamics of the disease in this population.

KW - Hepatitic C

KW - viruses

KW - re infection

KW - injecting drug users

UR - http://www.scopus.com/inward/record.url?scp=79953049415&partnerID=8YFLogxK

UR - http://www.ncbi.nlm.nih.gov/pubmed/21112759

U2 - 10.1016/j.drugpo.2010.10.007

DO - 10.1016/j.drugpo.2010.10.007

M3 - Article

VL - 22

SP - 102

EP - 108

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

SN - 0955-3959

IS - 2

ER -